(Q37466226)

20 August 2017

Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis (English)

1 reference

20 August 2017

Yasuhiro Miyake

1

1 reference

20 August 2017

Yoshiaki Iwasaki

2

1 reference

20 August 2017

Haruhiko Kobashi

3

1 reference

20 August 2017

Tetsuya Yasunaka

4

1 reference

20 August 2017

Fusao Ikeda

5

1 reference

20 August 2017

Akinobu Takaki

6

1 reference

20 August 2017

Ryoichi Okamoto

7

1 reference

20 August 2017

Kouichi Takaguchi

8

1 reference

20 August 2017

Hiroshi Ikeda

9

1 reference

20 August 2017

Yasuhiro Makino

10

1 reference

20 August 2017

Masaharu Ando

11

1 reference

20 August 2017

Kohsaku Sakaguchi

12

1 reference

20 August 2017

Kazuhide Yamamoto

13

1 reference

20 August 2017

22 October 2009

1 reference

20 August 2017

Hepatology international

1 reference

20 August 2017

3

1 reference

20 August 2017

4

1 reference

20 August 2017

556-562

1 reference

https://scigraph.springernature.com/pub.10.1007/s12072-009-9155-9

20 August 2017

0 references

cites work

Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790591

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790591

Classification of chronic hepatitis: diagnosis, grading and staging

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790591

Present status of autoimmune hepatitis in Japan--correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790591

Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progression?

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790591

Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790591

Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790591

Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790591

Diagnosis and treatment of autoimmune hepatitis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790591

Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790591

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790591

Immunomodulatory effects of ursodeoxycholic acid on immune responses

2 October 2018

1 reference

12 December 2020

Circulating levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in children with autoimmune hepatitis

1 reference

12 December 2020

Consequences of treatment withdrawal in type 1 autoimmune hepatitis

1 reference

12 December 2020

Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis

1 reference

12 December 2020

Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis

1 reference

12 December 2020

Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial

1 reference

12 December 2020

Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis

1 reference

12 December 2020

10.1007/S12072-009-9155-9

Identifiers

DOI

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19847577

1 reference